Pfizer's (NYSE:PFE) stock is up by a considerable 7.5% over the past month. However, we decided to pay attention to ...

Pfizer Inc. (NYSE:PFE) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider of Goldman ...

Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...

Pfizer (NYSE:PFE) announced robust sales for the antifungal drug Cresemba in partnership with Basilea Pharmaceutica Ltd, ...

Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the stock trades at its lowest levels in 13 years. Shares are down 19% over ...

Although Pfizer has made some efforts to turn things around, they have been insufficient. Pfizer's poor performance since 2022 is largely due to its coronavirus portfolio.

Dividend stocks can set you up for life. But, making the right choice will determine whether you enjoy a steady income or ...

Three supercharged dividend stocks have the tools and intangibles to fatten investors' pocketbooks in June, and well beyond.

Pfizer ( PFE -1.29%) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the biopharmaceutical industry to generate $100 billion in annual sales.

Pfizer (NYSE:PFE) recently ended its strategic collaboration with Acepodia and is facing legal challenges related to Depo-Provera, reflecting significant changes that provide a backdrop of strategic ...

Based on Pfizer’s latest earnings release for the quarter ending March 29, the company reported a quarterly revenue of $13.72 billion and a net profit of $2.97 billion. In comparison, last year the ...

Pfizer: Where's The Growth Catalyst? If you're a Pfizer Inc. (NYSE:PFE) investor, you have to really ask yourself whether it’s still worthwhile to stay on for the “grind,” as multitudinous ...